Sparstolonin B Reduces Cancer Cell Growth
Author Information
Author(s): Dilber Yağmur, Çeker Hanife Tuğçe, Öztüzün Aleyna, Çırçırlı Bürke, Kırımlıoğlu Esma, Barut Zerrin, Aslan Mutay, Fantacuzzi Marialuigia
Primary Institution: Akdeniz University
Hypothesis
Sparstolonin B could suppress estrogen-dependent cell proliferation in breast and ovarian cancer cells through the inhibition of the PI3K/AKT/mTOR signaling pathway.
Conclusion
Sparstolonin B decreases cancer cell viability and promotes apoptosis by downregulating key signaling proteins.
Supporting Evidence
- Sparstolonin B significantly decreased cell viability in MCF-7 and OVCAR-3 cells.
- Cancer cells treated with Sparstolonin B showed a significant drop in the levels of S1P, PI3K, p-AKT, and p-mTOR.
- Treatment with Sparstolonin B resulted in increased intracellular concentrations of ceramides and apoptosis.
Takeaway
Sparstolonin B is a substance that helps stop cancer cells from growing and makes them die, especially in breast and ovarian cancers.
Methodology
The study evaluated the effects of Sparstolonin B on cancer cell proliferation and apoptosis using various assays including MTT, ELISA, and immunofluorescence.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website